Overview

Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Face or Chest Including 12-month Follow-up

Status:
Completed
Trial end date:
2017-11-01
Target enrollment:
Participant gender:
Summary
The objective of the trial is to compare the short term efficacy of LEO 43204 gel with vehicle gel in AK on face or chest when applied topically once daily for 3 consecutive days as field treatment.
Phase:
Phase 3
Details
Lead Sponsor:
LEO Pharma